Influenza vaccines Safety data Main navigation COVID-19 vaccines Influenza vaccines <5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines AusVaxSafety commenced routine safety monitoring of 2022 seasonal influenza vaccines used in Australia across all ages in April 2022. The vaccines currently in use are Vaxigrip Tetra®, Fluarix Tetra®, Afluria® Quad (5 years and older), FluQuadri®, Flucelvax® Quad (2 years and older), Influvac® Tetra, Fluad® Quad (65 years and over) and Fluzone® High-Dose Quadrivalent (60 years and over). Surveillance data are provided by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. Latest influenza vaccine safety data Click on the tiles below to view 2022 AusVaxSafety influenza vaccine safety data for specific age and population groups. There are currently insufficient data to conduct meaningful analysis for the participants aged <5 years, Aboriginal and Torres Strait Islander participants and pregnant participants groups. Influenza vaccine safety data - <5 years View the latest safety data here Influenza vaccine safety data - 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data - 60 years and older (adjuvanted or high dose vaccine) View the latest safety data here Influenza vaccine safety data - Pregnant participants View the latest safety data here Influenza vaccine safety data - Aboriginal and Torres Strait Islander View the latest safety data here Safety data Main navigation COVID-19 vaccines Influenza vaccines <5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines News & events All news & events 28 July 2022 | News Safety of COVID-19 vaccines in >200,000 Aussie kids: reassuring data from AusVaxSafety 10 July 2022 | News AusVaxSafety study affirms safety of COVID-19 vaccines in real-world conditions 31 March 2022 | News AusVaxSafety commences routine monitoring of 2022 seasonal influenza vaccines 17 March 2022 | News Children experience fewer side effects from COVID-19 vaccine